Valuation (60%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 3.67 | N/A |
| PEG Ratio (TTM) | 0.04 | N/A |
| P/S Ratio (TTM) | 8.10 | N/A |
| P/B Ratio (TTM) | 1.11 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 9.49 | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 29.74% | N/A |
| ROE (TTM) | 30.44% | N/A |
| Net Profit Margin (TTM) | 220.82% | N/A |
| ROIC 5YR AVG | 8.50% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 80.89% | 138.57% | 86.67% |
| Revenue | 600.56% | 140.27% | 70.65% |
| Net Income | 80.34% | 138.45% | 86.59% |
| Cash Flow | N/A | N/A | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.71 | N/A |
| Quick Ratio (TTM) | 1.71 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 51.50 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 0.02% | N/A |